Connect with us


Weed-Tirement: James Altucher Launches a Seven-Figure Pot Pension Plan in the 21st Century




Weed-tirement is a guide that teaches consumers how to invest in cannabis stocks and potentially double their savings for retirement with minimal risks. The program is available from the official website, where consumers can download the content to review at their own pace.

What is Weed-Tirement?

Early on in every person’s career, the need to create a retirement fund arises. However, there’s no such thing as being too prepared, leading many consumers to invest in stocks that can grow that fund into an amount that offers comfortable living into retirement. The creators behind Weed-Tirement state that the investment in cannabis stocks could potentially grow this fund to twice what it already is.

Weed-Tirement: The Key to a Seven-Figure Pot Pension in the 21st Century guides consumers through the legal investment of pot stocks, which are some of the fastest growing stocks in the world today. The United States only recently legalized hemp across the nation, and cannabis is still only completely legal in some states. However, the creators of this program state that a small investment stands to bring back major returns for a healthier and more lucrative savings account.

The investment program works in a much similar way to a 401K program, but users will not have to wait decades to see any kind of results. Instead, the creator states that the user will start seeing payments soon after enrollment and throughout their investment experience. According to charts provided in the advertisement, cannabis sales raked in $10.4 billion last year, and projections show that this amount could easily grow by 200% in the next three years.


The company states that users just need to contribute $50 to the plan by September 12th to see the first payment by October 10th. Every year, the company guarantees four payouts yearly with no end in sight. It adds that there are some people already receiving payments as high as $57,000 for retirement, though long-term commitment will provide the best results.

Several times, the creators reiterate this program is a “low-risk/high-return opportunity.” According to the website, the plan managed to disperse $4,807,000,000, though the number of people that this was divided between was not provided.

Along with the Weed-Tirement plan, consumers who purchase this program will also get a guide titled “How to Cash in On The $15 Trillion Super Gadget: A Chance to Add as Much As $516,000 To Your Retirement This Year.” The technology is in reference to establishing a “driverless” society, and there are many financial publications that have already predicted that it will lead into the future of driving.

Purchasing Access to Weed-Tirement

The copy of How to Cash in On The $15 Trillion Super Gadget is entirely free, as well as Weed-Tirement. However, to gain access to the materials, consumers have to take on a risk-free trial of the Altucher’s Investment Network. The trial involves a subscription for $49, which is a markdown from the typical $299 annual cost.

Special Bonus Gift

Along with these materials, consumers will get an electronic copy of the 279-page eBook titled “The Choose Yourself Guide to Wealth.” This book is filled with tips from the creator on the investment secrets he uses to thrive in the economy, teaching consumers how to make money from investments in Amazon and how to eliminate debt.

Cryptocurrency Investment Materials

In addition to the aforementioned digital content, consumers will gain access to “Bitcoin’s Final Bull Run: 3 Penny Cryptos Set to Explode 10,000% or More in the Coming Weeks.” Cryptocurrency has been around for the last decade, but there are a substantial number of consumers that are still unfamiliar with the way that the industry works, or even how to invest.

Bitcoin has been gaining momentum in 2019, steadily recovering from the bear market that took over in 2018. At the time of writing, the original cryptocurrency showed a value of $11,606.89, despite losing 1% over the last 24 hours.

Contacting the Creators of Weed-Tirement

Even with all of this information, consumers may find that they have more questions about the program. The customer service team can be reached by filling out the online form at

The customer service team is available from 9:00am to 5:00pm EST on weekdays. They can also be reached by phone (1-844-449-6520) or by email (

Weed-Tirement Summary

Weed-Tirement, along with all of the other content, can only be accessed through an annual subscription. All of the materials can help consumers improve their retirement savings to secure their comfortable future. However, considering the three-month trial, consumers can give up their access to the materials if they do not gain the benefits that they expected from these materials.

Charnell Lock lives in sunny San Diego but is originally from North Carolina and has been writing professionally since 2011. After four years with the Navy and an Associate's Degree in Liberal Arts, Charnell found her passion in creating diverse content with well-formatted research. Along with her years in active duty service, she is capable of crafting whimsical short stories to medical-oriented papers as her capacity to contribute here is immense and will be a staple for many years to come.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.